BioTelemetry (BEAT) Tops Q2 EPS by 15c

BioTelemetry (NASDAQ: BEAT) reported Q2 EPS of $0.46, $0.15 better than the analyst estimate of $0.31. Revenue for the quarter came in at $101.4 million versus the consensus estimate of $95.86 million.

GUIDANCE:

BioTelemetry sees Q3 2018 revenue of $392-395 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• BMO Capital Starts Carter's (CRI) at Outperform
• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance